Obesity and childhood asthma in male schoolchildren in Saudi Arabia: Is there a role for leptin, interleukin-4, interleukin-5, and interleukin-21?


Journal

Annals of Saudi medicine
ISSN: 0975-4466
Titre abrégé: Ann Saudi Med
Pays: Saudi Arabia
ID NLM: 8507355

Informations de publication

Date de publication:
Historique:
entrez: 4 10 2019
pubmed: 4 10 2019
medline: 23 2 2020
Statut: ppublish

Résumé

Adiposity is associated with high serum levels of adipokines and chemokines which are possibly implicated in a co-existence of obesity and asthma. Elucidate the possible roles of leptin, interleukin (IL)-4, IL-5 and IL-21 in linking obesity with childhood asthma. Cross-sectional, analytical. Population of schoolchildren in a small Saudi city. The study included a representative sample of Saudi schoolchildren grouped as obese asthmatics, non-obese asthmatics, or obese nonasthmatics, with nonobese nonasthmatics as a control group. An asthma control test was done for the asthmatic groups. Serum levels of leptin, IL-4, IL-5, and IL-21. 345 male schoolchildren with a mean (SD) age of 13.0 (2.3) years. Median serum leptin concentrations in obese asthmatics were significantly higher than in nonobese asthmatics ( P<.001). Uncontrolled asthmatics also had significantly higher leptin levels than controlled asthmatic children ( P<.002). Leptin levels were weakly but significantly correlated with the cytokines IL-4, IL-5, and IL-21. Leptin may contribute to a link between obesity and childhood asthma. Differences in IL-21 levels between nonobese and obese asthmatics suggest that the co-existence of asthma and obesity increased IL-21 levels. Leptin plus some proinflammatory cytokines especially IL-21 may be potential predictors for asthma control in children. Blood sampling at different stages of asthma might influence cytokine expression. None.

Sections du résumé

BACKGROUND BACKGROUND
Adiposity is associated with high serum levels of adipokines and chemokines which are possibly implicated in a co-existence of obesity and asthma.
OBJECTIVES OBJECTIVE
Elucidate the possible roles of leptin, interleukin (IL)-4, IL-5 and IL-21 in linking obesity with childhood asthma.
DESIGN METHODS
Cross-sectional, analytical.
SETTING METHODS
Population of schoolchildren in a small Saudi city.
SUBJECTS AND METHODS METHODS
The study included a representative sample of Saudi schoolchildren grouped as obese asthmatics, non-obese asthmatics, or obese nonasthmatics, with nonobese nonasthmatics as a control group. An asthma control test was done for the asthmatic groups.
MAIN OUTCOME MEASURES METHODS
Serum levels of leptin, IL-4, IL-5, and IL-21.
SAMPLE SIZE METHODS
345 male schoolchildren with a mean (SD) age of 13.0 (2.3) years.
RESULTS RESULTS
Median serum leptin concentrations in obese asthmatics were significantly higher than in nonobese asthmatics ( P<.001). Uncontrolled asthmatics also had significantly higher leptin levels than controlled asthmatic children ( P<.002). Leptin levels were weakly but significantly correlated with the cytokines IL-4, IL-5, and IL-21.
CONCLUSIONS CONCLUSIONS
Leptin may contribute to a link between obesity and childhood asthma. Differences in IL-21 levels between nonobese and obese asthmatics suggest that the co-existence of asthma and obesity increased IL-21 levels. Leptin plus some proinflammatory cytokines especially IL-21 may be potential predictors for asthma control in children.
LIMITATIONS CONCLUSIONS
Blood sampling at different stages of asthma might influence cytokine expression.
CONFLICT OF INTEREST BACKGROUND
None.

Identifiants

pubmed: 31580718
doi: 10.5144/0256-4947.2019.295
pmc: PMC6832322
doi:

Substances chimiques

IL4 protein, human 0
IL5 protein, human 0
Interleukin-5 0
Interleukins 0
Leptin 0
Interleukin-4 207137-56-2
interleukin-21 MKM3CA6LT1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

295-301

Références

Pediatr Allergy Immunol. 2018 Mar;29(2):186-193
pubmed: 29314270
Arch Bronconeumol. 2010 Nov;46(11):587-93
pubmed: 20832159
Am J Respir Crit Care Med. 2017 Feb 1;195(3):314-323
pubmed: 27552676
Am J Epidemiol. 2003 Sep 1;158(5):406-15
pubmed: 12936895
Front Immunol. 2018 Jun 22;9:1445
pubmed: 29988381
J Asthma Allergy. 2016 Apr 04;9:71-81
pubmed: 27110133
Allergy. 2009 May;64(5):770-7
pubmed: 19210351
J Immunol. 2003 Jun 1;170(11):5359-66
pubmed: 12759409
Expert Rev Respir Med. 2011 Jun;5(3):377-93
pubmed: 21702660
Pharmacol Ther. 2017 Jan;169:57-77
pubmed: 27773786
Am J Respir Crit Care Med. 2017 May 1;195(9):1181-1188
pubmed: 28103443
J Asthma. 2017 Apr;54(3):279-285
pubmed: 27435689
Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):318-27
pubmed: 16932309
Endocr Metab Immune Disord Drug Targets. 2014;14(3):187-95
pubmed: 24862964
Immunol Rev. 2011 Jul;242(1):220-32
pubmed: 21682748
Pediatrics. 2016 May;137(5):
pubmed: 27244776
Thorax. 2006 Apr;61(4):300-5
pubmed: 16540481
J Breath Res. 2017 Sep 27;11(4):046005
pubmed: 28952460
Arch Bronconeumol. 2007 Mar;43(3):171-5
pubmed: 17386195
Hypertension. 1999 Jan;33(1 Pt 2):542-7
pubmed: 9931162
J Asthma. 2013 Mar;50(2):188-97
pubmed: 23259727
Pediatr Rheumatol Online J. 2017 Apr 20;15(1):32
pubmed: 28427414
Thorax. 2017 Feb;72(2):174-177
pubmed: 27672120
Nutr Res Rev. 2016 Dec;29(2):194-201
pubmed: 27514726
Thorax. 2002 Jul;57(7):581-5
pubmed: 12096199
Cell Immunol. 2004 Sep-Oct;231(1-2):133-45
pubmed: 15919378
J Allergy (Cairo). 2013;2013:654104
pubmed: 24454412
Front Pediatr. 2017 Dec 18;5:270
pubmed: 29326908
Respir Res. 2001;2(2):66-70
pubmed: 11686867
Ann Allergy Asthma Immunol. 2001 Mar;86(3):292-6
pubmed: 11289327
J Asthma. 2017 Nov;54(9):893-904
pubmed: 28635548
Allergol Immunopathol (Madr). 2017 May - Jun;45(3):258-264
pubmed: 28411906
Sci Rep. 2018 Jun 11;8(1):8905
pubmed: 29891850
Lancet. 2018 Jan 27;391(10118):292-294
pubmed: 28911917
NPJ Prim Care Respir Med. 2014 Jun 05;24:14004
pubmed: 24899344
BMC Public Health. 2011 Jul 08;11:542
pubmed: 21740558
Lancet. 2015 Sep 12;386(9998):1086-96
pubmed: 26383000
Malawi Med J. 2011 Mar;23(1):22-4
pubmed: 23638253
J Exp Med. 2006 Dec 25;203(13):2929-37
pubmed: 17178921
Saudi Med J. 2008 May;29(5):714-7
pubmed: 18454220
BMC Pulm Med. 2015 Jul 28;15:77
pubmed: 26216220
Biomed Res Int. 2018 May 23;2018:8102527
pubmed: 29951546
Lancet. 2000 Oct 21;356(9239):1369-70
pubmed: 11052573
Physiol Behav. 2014 May 10;130:157-69
pubmed: 24726399

Auteurs

Mohammed Al-Ayed (M)

From the Department of Pediatrics, College of Medicine, Najran University, Najran, Saudi Arabia.

Khalid Alshaybari (K)

From the Department of Pediatrics, College of Medicine, Najran University, Najran, Saudi Arabia.

Dhafer Alshehri (D)

From the Department of Pediatrics, College of Medicine, Najran University, Najran, Saudi Arabia.

Alzahrani Jamaan (A)

From the Department of Pediatrics, College of Medicine, Najran University, Najran, Saudi Arabia.

Iman Nasser (I)

From the Department of Pediatrics, College of Medicine, Najran University, Najran, Saudi Arabia.

Hamdan Alaamri (H)

From the Department of Pediatrics, Armed Forces Medical Services, Ministry of Defense, Najran, Saudi Arabia.

Wed Alaseeri (W)

From the Department of Pediatrics, Ministry of Health, Saudi Arabia.

Ahmed A Mahfouz (AA)

From the Department of Family Community Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia.

Saeed Ali Alsareli (S)

From the General Surgery Department, University of Najran, Saudi Arabia.

Ahmed Morad Asaad (AM)

From the Department of Microbiology, College of Medicine, Najran University, Najran, Saudi Arabia.

Aamir Ali Magzoub (A)

From the Department Physiology, College of Medicine, Najran University, Najran, Saudi Arabia.

Mohamed Ansar Qureshi (MA)

From the Department of Microbiology, College of Medicine, Najran University, Najran, Saudi Arabia.

Mohammed Helmy Shalayel (MH)

From the Department of Biochemistry, College of Medicine, Najran University, Najran, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH